Cautious Optimism for Inventiva’s Lanifibranor Amidst Execution Challenges and Dilution Risks
Inventiva (IVA) has received a new Hold rating, initiated by UBS analyst, Eliana Merle. Eliana Merle’s rating is based on the promising ...
Business Insider3d
Strong Buy Recommendation for Akero Therapeutics Driven by Promising Clinical Trials and Solid Financial Position
Additionally, two other studies, SYNCHRONY Real-World and SYNCHRONY Histology, are expected to deliver top-line ... you will gain access to this exclusive data and discover crucial insights to guide ...